THE MNISTRY OF HEALTH

-------

SOCIALIST REPUBLIC OF VIET NAM
Independence - Freedom - Happiness
----------

No: 19/2014/TT-BYT

Hanoi, June 02, 2014

 
 

CIRCULAR

Managing the addictive drugs, psychotropic drugs, and drug precursor substances

Pursuant to the Law on Pharmacy No. 34/2005/QH11 dated June 14, 2005;
Pursuant to the Law on Narcotic Control No. 23/2000/QH10 dated December 19, 2000 and the Law No. 16/2008/QH12 dated June 03, 2008 on amendments to the Law on Narcotic Control;
Pursuant to the Government's Decree No. 79/2006/ND-CP dated August 09th 2006, specifying the implementation of a number of articles of the Law on Pharmacy;
Pursuant to the Government's Decree No. 89/2012/ND-CP dated October 24, 2012 on amendments to the Decree No. 79/2006/ND-CP;
Pursuant to the Government's Decree No. 80/2001/ND-CP dated November 05, 2001 on guidelines for control of lawful activities pertaining to narcotics in Vietnam;
Pursuant to the Government's Decree No. 58/2003/ND-CP dated May 19, 2003 on control of import, export, transit of narcotic substances, precursor substances, addictive drugs, and psychotropic drugs;
Pursuant to the Government's Decree No. 82/2013/ND-CP dated July 19, 2013 on promulgation of the list of narcotic substances and drug precursor substances;
Pursuant to the Government's Decree No. 63/2012/ND-CP dated August 31st 2012 defining the functions, tasks, powers and organizational structure of the Ministry of Health;
At the request of the Director of Drug Administration of Vietnam,
The Minister of Health promulgates a Circular on management of addictive drugs, psychotropic drugs, and drug precursor substances.
Chapter I
GENERAL REGULATIONS
Article 1. Scope of adjustment and subjects of application
This Circular deals with activities pertaining to addictive drugs, psychotropic drugs, drug precursor substances, commercial combined drugs that contain addictive ingredients, commercial combined drugs that contain psychotropic ingredients, commercial combined drugs that contain drug precursor substances used for healthcare, analysis, testing, and scientific research by organizations and individuals (hereinafter referred to as entities) in Vietnam and overseas.
Article 2. Interpretation of terms
In this Circular, the terms below are construed as follows:
1. Addictive drugs include:
a) Raw materials that contain addictive ingredients listed in Appendix I.
b) Semi-finished products that contain any of the addictive ingredients listed in Appendix I.
c) Commercial drugs that contain any of the addictive ingredients listed in Appendix I, regardless of concentration.
d) Commercial drugs that contain an addictive ingredient in combination with other active ingredients, the concentration of additive ingredients in which is higher than the level prescribed in Appendix II.
dd) Commercial drugs that contain an addictive ingredient in combination with other addictive ingredients; commercial drugs that contain an addictive ingredient in combination with psychotropic ingredients; commercial drugs that contain an addictive ingredient in combination with a drug precursor; commercial drugs that contain an addictive ingredient in combination with psychotropic ingredients and drug precursor substances, regardless of concentration of addictive ingredients, psychotropic ingredients, and drug precursor substances.
2. Finished addictive drugs are drugs specified in Points c, d, and dd Clause 1 of this Article.
3. Commercial combined drugs that contain addictive ingredients are commercial drugs that satisfy all requirements below:
a) Contain active ingredients other than addictive ingredients, psychotropic ingredients, and drug precursor substances;
b) Contain addictive ingredients; or contain addictive ingredients in combination with psychotropic ingredients; or contain addictive ingredients in combination with drug precursor substances; or contain addictive ingredients in combination with psychotropic ingredients and drug precursor;
*All appendices are not translated herein.